ProShare Advisors’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-31,306
| Closed | -$2.66M | – | 1770 |
|
|
2019
Q4 | $2.66M | Sell |
31,306
-2,380
| -7% | -$159K | 0.01% | 561 |
|
|
2019
Q3 | $1.68M | Buy |
33,686
+1,343
| +4% | +$53.6K | 0.01% | 627 |
|
|
2019
Q2 | $1.18M | Sell |
32,343
-4,785
| -13% | -$156K | 0.01% | 706 |
|
|
2019
Q1 | $1.04M | Buy |
37,128
+1,065
| +3% | +$25.1K | 0.01% | 743 |
|
|
2018
Q4 | $690K | Sell |
36,063
-6,428
| -15% | -$150K | ﹤0.01% | 826 |
|
|
2018
Q3 | $1.27M | Sell |
42,491
-1,149
| -3% | -$43.3K | 0.01% | 721 |
|
|
2018
Q2 | $1.6M | Sell |
43,640
-2,623
| -6% | -$85.2K | 0.01% | 667 |
|
|
2018
Q1 | $1.52M | Sell |
46,263
-6,938
| -13% | -$217K | 0.01% | 681 |
|
|
2017
Q4 | $1.46M | Buy |
53,201
+4,777
| +10% | +$147K | 0.01% | 707 |
|
|
2017
Q3 | $1.79M | Buy |
48,424
+2,695
| +6% | +$99.3K | 0.02% | 584 |
|
|
2017
Q2 | $1.74M | Sell |
45,729
-2,988
| -6% | -$133K | 0.02% | 594 |
|
|
2017
Q1 | $2.38M | Sell |
48,717
-11,414
| -19% | -$521K | 0.02% | 513 |
|
|
2016
Q4 | $2.04M | Buy |
60,131
+5,636
| +10% | +$200K | 0.02% | 544 |
|
|
2016
Q3 | $2.06M | Sell |
54,495
-7,463
| -12% | -$281K | 0.03% | 483 |
|
|
2016
Q2 | $2.08M | Buy |
61,958
+730
| +1% | +$25.7K | 0.03% | 498 |
|
|
2016
Q1 | $1.95M | Sell |
61,228
-5,982
| -9% | -$195K | 0.03% | 467 |
|
|
2015
Q4 | $2.51M | Buy |
67,210
+8,717
| +15% | +$329K | 0.03% | 438 |
|
|
2015
Q3 | $2.22M | Sell |
58,493
-3,983
| -6% | -$140K | 0.03% | 457 |
|
|
2015
Q2 | $1.79M | Sell |
62,476
-4,551
| -7% | -$127K | 0.02% | 549 |
|
|
2015
Q1 | $1.88M | Buy |
67,027
+8,083
| +14% | +$227K | 0.02% | 584 |
|
|
2014
Q4 | $1.63M | Sell |
58,944
-2,087
| -3% | -$51.7K | 0.02% | 638 |
|
|
2014
Q3 | $1.36M | Sell |
61,031
-12,691
| -17% | -$322K | 0.02% | 936 |
|
|
2014
Q2 | $2.14M | Sell |
73,722
-40,649
| -36% | -$1.09M | 0.03% | 698 |
|
|
2014
Q1 | $3.25M | Buy |
114,371
+80,970
| +242% | +$2.68M | 0.04% | 462 |
|
|
2013
Q4 | $1.29M | Sell |
33,401
-29,820
| -47% | -$1.07M | 0.02% | 913 |
|
|
2013
Q3 | $2.12M | Buy |
63,221
+14,465
| +30% | +$461K | 0.05% | 373 |
|
|
2013
Q2 | $1.5M | Buy |
+48,756
| New | +$1.63M | 0.03% | 605 |
|
Other funds holding MDCO
ProShare Advisors's MDCO Position: Q1 2020 in Review
ProShare Advisors sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 31,306 shares — an estimated $2.66M sold.
ProShare Advisors first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $3.25M in Q1 2014. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- ProShare Advisors reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- ProShare Advisors sold 31,306 Medicines Co shares in Q1 2020, an estimated $2.66M.
- ProShare Advisors first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- ProShare Advisors's Medicines Co position peaked at $3.25M in Q1 2014.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on ProShare Advisors's 13F filing for Q1 2020, filed 15 May 2020.